Clinical Trial Update: To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial Intelligence [NA]

View source ↗

Summary

A clinical trial sponsored by The Chinese University of Hong Kong is evaluating an AI-powered MRI-based diagnostic pathway for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Prostate Cancer | NA | Status: RECRUITING